Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?

J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e543-e545. doi: 10.1111/jdv.17340. Epub 2021 May 28.

Authors

C Mazzatenta¹, V Piccolo², G Pace³, I Romano⁴, G Argenziano², A Bassi¹

Affiliations

¹ UO Dermatologia Lucca- Azienda USL Toscana Nordovest, Lucca, Italy.
² Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
³ Pediatrician Self Employed, Treviso, Italy.
⁴ Dermatology Unit - Department of Medicine DIMED, University of Padua, Padova, Italy.

No abstract available

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Eyelids
Humans
RNA, Messenger
SARS-CoV-2*

Substances

COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine